Kodiak Sciences (KOD) Current Leases (2019 - 2026)
Kodiak Sciences (KOD) reported Current Leases of $11.7 million for Q1 2026, up 6.5% on a YoY basis from $10.9 million in Q1 2025, and down 3.34% quarter-over-quarter from $12.1 million in Q4 2025.
Kodiak Sciences (KOD) Current Leases (2019 - 2026) Analysis & Trends
Kodiak Sciences has reported Current Leases for 8 years, with the latest figure at $11.7 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 6.5% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.7 million (up 6.5% YoY), and the FY2025 full-year result was $12.1 million, up 13.5% from the prior year.
- Current Leases for Q1 2026 stood at $11.7 million, down from $12.1 million in the prior quarter.
- The five-year high for Current Leases was $12.1 million in Q4 2025, with the low at $5.0 million in Q1 2022.
- Historically, Current Leases has averaged $9.6 million across 5 years, with a median of $9.9 million in 2024.
- Annual changes were most pronounced in 2022 — Current Leases soared 463.8% — and 2023, when it dropped 1.57%.
- Kodiak Sciences' Current Leases stood at $9.9 million in 2022, then dropped by 1.57% to $9.8 million in 2023, then rose by 8.78% to $10.6 million in 2024, then gained by 13.5% to $12.1 million in 2025, then fell by 3.34% to $11.7 million in 2026.
- The last three Current Leases figures came in at $11.7 million (Q1 2026), $12.1 million (Q4 2025), and $11.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 11.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.66 Mn |
| Dec 31, 2025 | 12.06 Mn |
| Sep 30, 2025 | 11.75 Mn |
| Jun 30, 2025 | 11.29 Mn |
| Mar 31, 2025 | 10.95 Mn |
| Dec 31, 2024 | 10.63 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Mar 31, 2024 | 9.61 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | 9.02 Mn |
| Jun 30, 2023 | 7.85 Mn |
| Mar 31, 2023 | 7.94 Mn |
| Dec 31, 2022 | 9.93 Mn |
| Sep 30, 2022 | 9.13 Mn |
| Jun 30, 2022 | 6.04 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 3.93 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 1.25 Mn |